Cohort Profile: The Swiss HIV Cohort Study
Top Cited Papers
Open Access
- 3 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 39 (5) , 1179-1189
- https://doi.org/10.1093/ije/dyp321
Abstract
The Swiss HIV Cohort study (SHCS) was established in 1988. It is an ongoing multicentre, prospective observational study for interdisciplinary human immunodeficiency virus (HIV) research in clinical, translational, basic, epidemiological and social sciences, and for addressing public health questions. It started with the enrolment of HIV-infected adults aged ≥16 years in a multicentre study and originally was financed by the Swiss Federal Office of Public Health (FOPH). Some data going back to 1981 have been collected retrospectively. In 1995, the SHCS was reorganized with a clear separation between research and infrastructure budget. A Scientific Board, responsible for the evaluation of nested research projects within a defined budget envelop, was established. Moreover, each centre has been compensated/penalized according to its performance and, last but not least, quality control programmes have been implemented. In 2000 the representatives of clinics and laboratories were merged in the Clinics & Laboratories Committee. At the same time, funding was transferred from the FOPH to the Swiss National Science Foundation (SNSF).Keywords
This publication has 89 references indexed in Scilit:
- HIV rebounds from latently infected cells, rather than from continuing low-level replicationProceedings of the National Academy of Sciences, 2008
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patientsAIDS, 2008
- Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish Journal of Cancer, 2008
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid‐Lowering Drugs in HIV‐Infected Individuals and Impact on Myocardial InfarctionClinical Infectious Diseases, 2008
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaborationThe Lancet, 2008
- Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income CountriesClinical Infectious Diseases, 2007
- Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesAIDS, 2007
- Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1Nature Genetics, 2007